These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 22695719)

  • 21. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
    Cong X; Topin J; Golebiowski J
    Curr Pharm Des; 2017 Nov; 23(29):4390-4409. PubMed ID: 28699533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights from structural biology into the druggability of G protein-coupled receptors.
    Mason JS; Bortolato A; Congreve M; Marshall FH
    Trends Pharmacol Sci; 2012 May; 33(5):249-60. PubMed ID: 22465153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural models of class a G protein-coupled receptors as a tool for drug design: insights on transmembrane bundle plasticity.
    Deupi X; Dölker N; López-Rodríguez ML; Campillo M; Ballesteros JA; Pardo L
    Curr Top Med Chem; 2007; 7(10):991-8. PubMed ID: 17508932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence, structure and ligand binding evolution of rhodopsin-like G protein-coupled receptors: a crystal structure-based phylogenetic analysis.
    Wolf S; Grünewald S
    PLoS One; 2015; 10(4):e0123533. PubMed ID: 25881057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of the ligand-free G-protein-coupled receptor opsin.
    Park JH; Scheerer P; Hofmann KP; Choe HW; Ernst OP
    Nature; 2008 Jul; 454(7201):183-7. PubMed ID: 18563085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs.
    McCorvy JD; Butler KV; Kelly B; Rechsteiner K; Karpiak J; Betz RM; Kormos BL; Shoichet BK; Dror RO; Jin J; Roth BL
    Nat Chem Biol; 2018 Feb; 14(2):126-134. PubMed ID: 29227473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural insights into agonist-induced activation of G-protein-coupled receptors.
    Deupi X; Standfuss J
    Curr Opin Struct Biol; 2011 Aug; 21(4):541-51. PubMed ID: 21723721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment and challenges of ligand docking into comparative models of G-protein coupled receptors.
    Nguyen ED; Norn C; Frimurer TM; Meiler J
    PLoS One; 2013; 8(7):e67302. PubMed ID: 23844000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide recognition, signaling and modulation of class B G protein-coupled receptors.
    Cao C; Zhang H; Yang Z; Wu B
    Curr Opin Struct Biol; 2018 Aug; 51():53-60. PubMed ID: 29567494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structures of G protein-coupled receptors reveal new opportunities for drug discovery.
    Cooke RM; Brown AJ; Marshall FH; Mason JS
    Drug Discov Today; 2015 Nov; 20(11):1355-64. PubMed ID: 26303408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular signatures of G-protein-coupled receptors.
    Venkatakrishnan AJ; Deupi X; Lebon G; Tate CG; Schertler GF; Babu MM
    Nature; 2013 Feb; 494(7436):185-94. PubMed ID: 23407534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
    Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
    Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-Based Virtual Screening for Ligands of G Protein-Coupled Receptors: What Can Molecular Docking Do for You?
    Ballante F; Kooistra AJ; Kampen S; de Graaf C; Carlsson J
    Pharmacol Rev; 2021 Oct; 73(4):527-565. PubMed ID: 34907092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural perspective of class B1 GPCR signaling.
    Cong Z; Liang YL; Zhou Q; Darbalaei S; Zhao F; Feng W; Zhao L; Xu HE; Yang D; Wang MW
    Trends Pharmacol Sci; 2022 Apr; 43(4):321-334. PubMed ID: 35078643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K
    Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New G-protein-coupled receptor crystal structures: insights and limitations.
    Kobilka B; Schertler GF
    Trends Pharmacol Sci; 2008 Feb; 29(2):79-83. PubMed ID: 18194818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
    Bermudez M; Wolber G
    Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From G Protein-coupled Receptor Structure Resolution to Rational Drug Design.
    Jazayeri A; Dias JM; Marshall FH
    J Biol Chem; 2015 Aug; 290(32):19489-95. PubMed ID: 26100628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.
    Lee SM; Booe JM; Pioszak AA
    Eur J Pharmacol; 2015 Sep; 763(Pt B):196-205. PubMed ID: 25981303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.